Search results for: Use of Medicines

NICE at 25: Technology Appraisals – Faster Access to Modern Treatment?

1 May 2024

…methods and thresholds used. The launch of four medicines for renal cancer provided a focus for these pressures, raising the question of whether there should be instances where patients should…

International Comparison of Medicines Usage: Quantitative Analysis from a Swedish Perspective

1 May 2015

…different classes of medicines. In a majority of classes usage is below the two international averages. But while, for example, usage of cardiovascular medicines is low by international standards, use…

Plan For A New EU Pharmaceutical Legislation: What Will It Mean For Pharmaceutical Innovation?

12 April 2024

…of where they live in the EU; To offer an attractive innovation- and competitiveness- friendly environment for research, development, and production of medicines in Europe; To address antimicrobial resistance (AMR)…

OHE Develops New, Bottom-Up Model for Forecasting UK Medicines Expenditure

3 April 2013

…useful in planning NHS resource allocation. Simple extrapolations of past trends in medicines expenditure, however, are insufficient because they cannot account for shifts in the mix of medicines available on…

Projecting Expenditure on Medicines in the NHS

4 January 2013

…scrutiny in efforts to manage costs. Forecasting spending on medicines can be useful… Medicines account for less than 10% of total NHS expenditure in the UK. Because spending on medicines…

Terms and Conditions

…or revenue; o loss of business; o loss of profits or contracts; o loss of anticipated savings; o loss of data; o loss of goodwill; o wasted management or office time; and o for any other loss…

Rare Disease Day 2024: Why Do We Care About Rare?

29 February 2024

…a diagnosis; Opportunities for treatment are often limited: only about 5% of rare diseases have an approved treatment; Coordination of care is difficult because multiple medical disciplines are often involved:…

Routine Funding in the NHS in the UK of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure

1 December 2017

…and orphan medicines. We utilised a database of outcomes of health technology assessment (HTA) evaluations conducted in the UK by NICE, AWMSG and SMC: OHE’s Medicines Tracker. We considered centrally…

A Critique of the Paper “The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List”

1 May 2018

…the cost of manufacturing essential medicines to inform negotiations on drug pricing. The OHE Consulting Report argues against use of a costing exercise to negotiate generic drug prices irrespective of…